Probable Olanzapine-Related Idiopathic Intracranial Hypertension in an Adolescent with First-Episode Psychosis

Name: Probable Olanzapine-Related Idiopathic Intracranial Hypertension in an Adolescent with First-Episode Psychosis
SKU: 26342
Price: 30.00 USD
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 53 No. 3 Articles 2023 Tags: adolescent, Ahmed Naguy, Camellia Naguy, early-onset schizophrenia, olanzapine, pseudotumour cerebri, Sanaa Sabir

Description

Description

Complicated Case Histories

Probable Olanzapine-Related Idiopathic Intracranial Hypertension in an Adolescent with First-Episode Psychosis

Ahmed Naguy, Camellia Naguy, Sanaa Sabir

Probable Olanzapine-Related Idiopathic Intracranial Hypertension in an Adolescent with First-Episode Psychosis

Description

Complicated Case Histories

Michael W. Jann, PharmD, FCCP, BCPP: Switching Antipsychotic Drugs: A Pharmacokinetic, Pharmacodynamic, and Practical Perspective

Psychopharmacology Bulletin VOL 47 No. 1, 2017 – Full Issue Stacked PDF

Vicki L. Ellingrod, PharmD, BCPP: Leptin and Leptin Receptor Gene Polymorphisms and Increases in Body Mass Index (BMI) from Olanzapine Treatment in Persons with Schizophrenia

Patricia K. Corey-Lisle, PhD, RN,CS-P: Economic Impact of Olanzapine Plus Fluoxetine Combination Therapy Among Patients Treated for Depression: A Pilot Study

Probable Olanzapine-Related Idiopathic Intracranial Hypertension in an Adolescent with First-Episode Psychosis

Description

Complicated Case Histories

Related products

Michael W. Jann, PharmD, FCCP, BCPP: Switching Antipsychotic Drugs: A Pharmacokinetic, Pharmacodynamic, and Practical Perspective

Psychopharmacology Bulletin VOL 47 No. 1, 2017 – Full Issue Stacked PDF

Vicki L. Ellingrod, PharmD, BCPP: Leptin and Leptin Receptor Gene Polymorphisms and Increases in Body Mass Index (BMI) from Olanzapine Treatment in Persons with Schizophrenia

Patricia K. Corey-Lisle, PhD, RN,CS-P: Economic Impact of Olanzapine Plus Fluoxetine Combination Therapy Among Patients Treated for Depression: A Pilot Study